Sign in or Create an account to bookmark this page
Click here to bookmark this page
Click here to remove bookmark
Sign in or Create an account to bookmark this page
Click here to bookmark this page
Click here to remove bookmark
In this edition of Duff & Phelps’ European Chemicals Update, we evaluate current trends for key raw materials, prevailing investor sentiment and valuation developments in the featured pharma chemicals sub-sector.
Our top insights are detailed below.
Key raw materials in the chemicals sector trended downward in Q1/Q2 2020, following a steep fall in crude oil prices. Output cuts, macroeconomic concerns and a fall in demand from COVID-19 continued to suppress Brent crude prices in Q2 2020. This trend will likely prevail until the end of the year.
Next, the ifo Business Climate Index for the German chemical industry remained negative in Q2 2020. Current conditions trended further downward in Q2 2020; however, expectations reversed into positive territory, implying that companies are optimistic for the near future, despite current challenges.
Finally, in the pharma chemicals sub-sector, market capitalization increased for the featured companies, driven by a strong period of demand resulting from the pandemic.
Comprehensive support throughout mergers and acquisitions and other corporate transactions.
Middle-market M&A advisory differentiated by industry expertise and superior deal execution.
Industrials expertise for middle-market M&A transactions.
Seamless analytical advisory through the deal continuum, from transaction origination to closing.
Independent opinions for boards of directors and special committees.
Dedicated coverage and access to M&A deal-flow for financial sponsors.
Financial and operational solutions for distressed and special situations.
Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.
Valuation and consulting for financial reporting, federal, state and local tax, investment and risk management purposes.